Manchester City’s week is moving along sweetly, this win closing the gap to three points to Arsenal, who travel to Brentford on Thursday. On Sunday, they beat Liverpool at Anfield, on Wednesday they downed Fulham at home, to reel off a 20th consecutive victory against them. The rosiest moment for the title challengers was Erling Haaland’s 39th‑minute strike, a first in the competition from open play in nine games, though Pep Guardiola will be concerned at how City still grasp for supreme control. Haaland was removed at the break – maybe due to being hurt – so this is a concern, but a clean sheet plus scoring three times raises the goal difference to +30, two behind Arsenal. Who knows: the metric may prove the decider when the crown is handed out in May. You had to go back to April 2009 for the last time Fulham defeated City when a Clint Dempsey double helped them to secure a 3-1 win here. Since then, the aggregate score was 53‑21 to the home team – a terrible statistic for the visitors. Guardiola, then, in saying nice things pre-game about Marco Silva, could be read as patronising, though he has been in charge only since July 2021. Phil Foden, back in the league XI for the first time in five games, had a goalbound volley from outside the area deflected, Then, from inside the area, a shot that was saved low by Bernd Leno. In continual rain, Silva bemoaned Harry Wilson going backwards along the right, but a press featuring Antoine Semenyo, Haaland, Nico O’Reilly, Foden and Rodri meant scant other choice. Guardiola approved of this, but was less enamoured with two loose O’Reilly passes and one from Foden: each time attacking positions were spurned, and when Alex Iwobi ran through and shot for Fulham the wastefulness felt worse. View image in fullscreen Antoine Semenyo slides home Manchester City’s first goal against Fulham. Photograph: Paul Ellis/AFP/Getty Images That was until Semenyo scored at the other end. Rodri sprayed a pass left to Matheus Nunes, the right‑back ...

In this article META Follow your favorite stocks CREATE FREE ACCOUNT Instagram CEO Adam Mosseri testifies at a U.S. Senate hearing in Washington, D.C., on Dec. 8, 2021. Brendan Smialowski | AFP | Getty Images Instagram chief Adam Mosseri said Wednesday during testimony in a high-profile social media trial that he thinks there can be problematic usage of social media, but does not think it constitutes an addiction. "I'm sure I said this, but I think it's important to differentiate between clinical addiction and problematic use," said Mosseri, who noted several times that he is not a medical professional. Mosseri said that sometimes the use of the word addiction can refer to something more casually, and noted that while he may have once said he was addicted to a Netflix show, that's not an actual clinical addiction. "So it's a personal thing, but yeah, I do think it's possible to use Instagram more than you feel good about," Mosseri said. "Too much is relative, it's personal." Mosseri testified in Los Angeles Superior Court, where the plaintiff alleges that social media platforms Meta , YouTube, TikTok and Snap misled the public about the safety of their apps while knowing certain design choices and features fostered detrimental mental health effects in young users. Although TikTok and Snap were originally part of the case, the two companies are no longer involved after settling with a plaintiff involved in the lawsuit. "The question for the jury in Los Angeles is whether Instagram was a substantial factor in the plaintiff's mental health struggles," a Meta spokesperson said. The LA trial centers around a plaintiff listed as "KGM" and her mother, who allege that the tech companies designed features like infinite scroll that resulted in addictive behavior and negative mental health issues. "The evidence will show she faced many significant, difficult challenges well before she ever used social media," the Meta spokesperson said in a statement. Mark Lanier, the plaintif...

Pilgrim's Pride press release ( PPC ): Q4 Non-GAAP EPS of $0.68 misses by $0.08 . Revenue of $4.52B (+3.4% Y/Y) beats by $130M . More on Pilgrim's Pride Pilgrim's Pride: Broiler Chickens, Hidden Potential And Stable Demand. Pilgrim's Pride Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Pilgrim's Pride Historical earnings data for Pilgrim's Pride Financial information for Pilgrim's Pride

McDonald’s reported the fastest growth in comparable sales, both in the U.S. and globally, in more than two years.

Seeking Alpha Seeking Alpha More on Albemarle Don't Chase Albemarle Here (Rating Downgrade) Albemarle: Leveraging It All On Lithium Albemarle: The Top Lithium Pick In 2026 Albemarle Non-GAAP EPS of -$0.53 misses by $0.04, revenue of $1.43B beats by $80M Albemarle Q4 2025 Earnings Preview

Lilah Fear and Lewis Gibson missed out on becoming the first British figure skaters in 32 years to win an Olympic medal, as they failed to make the ice dance podium at Milan-Cortina 2026. Fear tripped on the second element of their free-dance routine, and despite skating cleanly for the remainder it proved too much of an obstacle to overcome. After an embrace on the ice, Fear and Gibson left the rink to applause from the large British presence in the crowd. Fear was visibly upset as the scores came in to confirm they would not claim a place on the podium. It means the wait goes on for British skating since Dame Jayne Torvill and Sir Christopher Dean won bronze at the Lillehammer Games in 1994. And it continues Team GB's disappointing Games so far, with no medals won yet.

Earnings Call Insights: Royalty Pharma (RPRX) Q4 2025 Management View CEO Pablo Legorreta stated that "2025 was truly a landmark year for Royalty Pharma as we executed successfully towards our goal to be the premier capital allocator in life sciences with consistent compounding growth." He highlighted strong double-digit growth in both portfolio receipts and royalty receipts and noted that full year results were delivered "slightly above the top end of our most recent update." Legorreta pointed to a 15.8% return on invested capital and a 22.8% return on invested equity for the year. Legorreta announced that Royalty Pharma completed the internalization of its external manager, resulting in improved alignment, governance, and "a significant reduction in costs." He noted capital deployment of $2.6 billion, $4.7 billion in announced transactions, and $1.7 billion returned to shareholders via $1.2 billion in buybacks and over $500 million in dividends, including a 7% dividend increase in Q1 2026. Legorreta referenced several positive clinical and regulatory updates, including FDA approval of Myqorzo and positive Phase III results for Tremfya, TEV-749, deucrictibant, and Trodelvy. He emphasized the company's underappreciated development-stage pipeline and expected "multiple pivotal readouts in the relatively near future." Vice Chairman Christopher Hite explained that "2025 was our strongest year ever for synthetic royalty transactions with 4 synthetic deals totaling more than $2 billion," and noted a record market value for synthetic royalties. Hite highlighted increased Board and C-suite interest in synthetic royalties as a funding modality and said, "we are optimally positioned to benefit from this important paradigm shift." Executive VP of Research & Investments Marshall Urist detailed capital deployment of close to $900 million in Q4 and total annual deployment of $2.6 billion, with 67% of investments in approved products and 33% in development-stage therapies. Urist ...

格隆汇2月12日｜美联储哈玛克：我认为利率不会对经济造成太大抑制作用。

The stock market closed mostly lower on Wednesday as investors’ enthusiasm waned after the January nonfarm payrolls report , which showed a surprising 130,000 jobs added vs. the 70,000 the market expected. The benchmark S&P 500 ( SP500 ) ended virtually unchanged, while the Nasdaq Composite ( COMP:IND ) closed -0.2%, and the blue-chip Dow ( DJI ) finished -0.1%. Yields in the bond market rose after the jobs report, with the 10-year Treasury yield ( US10Y ) rising 3 basis points to 4.18%, while the 2-year yield ( US2Y ) was 6 basis points higher at 3.52%. Now, here are the top three things to expect on Thursday: Companies such as Cisco Systems ( CSCO ), McDonald’s ( MCD ), and AppLovin ( APP ), among others, will report earnings today after-hours and might move the markets on Thursday. Among the companies reporting on Thursday, Applied Materials ( AMAT ), Arista Networks ( ANET ), Vertex Pharmaceuticals ( VRTX ), and Howmet Aerospace ( HWM ), to name a few. Applied Materials ( AMAT ) is expected to report a revenue of $6.88B, while Arista Networks’ ( ANET ) consensus for revenue is $2.39B. On the economic calendar, investors will receive the initial jobless claims and existing home sales during market hours. Initial jobless claims for the previous week showed an increase of 22,000 to 231,000; while existing home sales rose 5.1% month-over-month to a seasonally adjusted annual rate of 4.35M in December. More on the markets January Jobs Blowout Masks Slowing Private Economy Stocks Grind Higher, But Early Signs Of A Defensive Shift Emerging January Jobs Report: Smashing Expectations U.S. stocks end in the red as nonfarm payrolls shock wanes SA analysts weigh in on January jobs data: Reaction Roundup

WOODLAND PARK, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced its third quarter fiscal 2026 results and filed its Form 10-Q for the three and nine months ended December 31, 2025. The Company also issued an update on its Demonstrated Intent metric which can be found on Anterix’s website at https://investors.anterix.com/events-presentations. Financial and Operational Highlights Approximately $123 million of contracted proceeds outstanding with line of sight to payment of over $80 million of outstanding contracted proceeds in the fourth quarter of fiscal 2026 Exchanged narrowband for broadband licenses in 12 counties and recorded a $0.8 million gain on exchange of broadband licenses Delivered broadband licenses covering 10 counties to customers and recorded a $0.3 million gain on sale of broadband licenses Invested $3 million in spectrum clearing costs Continued to advance approximately $3 billion pipeline of prospective contract opportunities across 60+ potential customers On January 27, 2026, the Federal Communications Commission (the “FCC”) announced a vote to expand the 900 MHz broadband allocation from 6 MHz to 10 MHz, a milestone stemming from Anterix’s joint petition expected to significantly enhance private wireless broadband capabilities for utilities and critical infrastructure providers On January 30, 2026, the Company entered into a new spectrum sale agreement with CPS Energy for a total contract price of $13 million with 50% payable upfront, and the remaining 50% payable at the end of our fiscal 2027 Liquidity and Balance Sheet At December 31, 2025, the Company had no debt and cash and cash equivalents of $29.5 million. In addition, the Company had a restricted cash balance of $8.4 million in escrow deposits. The Company has an authorized share repurchase program for up to $250 million of the Company’s common stock on or before September 21, 2026. In the fiscal 2026 third quarter, Anterix had no share repurchase activity. As...

The technology sector's slack start to 2026 is a good news/bad news proposition. Investors may view the technology sector as sprawling, and they wouldn't be entirely off-base. The Technology Select Sector index, which houses the S&P 500's tech components, includes 70 stocks from seven industries. As a result, tech exchange-traded funds (ETFs) can also deliver disparate performances, and what's playing out in the early stages of 2026 is a reminder of that fact. For example, the tech-heavy Nasdaq-100 is off 2% this year. A 2% dip in less than two months is enough for many investors to endure, but some tech ETFs are the worse for wear. Much, much worse. That's the negative news. On the positive side of things, tech weakness is creating buying opportunities for discerning investors, meaning there are some ETFs out there that merit buying hand over fist. Dark clouds hang over this ETF Investors who devoted just a few minutes to market headlines in recent weeks likely know that software stocks are being drubbed. As of Feb. 6, software equities shed a combined $1 trillion in market value amid fears that emerging artificial intelligence (AI) tools are making some software programs obsolete. Cloud computing stocks are enduring their share of punishment, and that brings us to the $2.47 billion First Trust Cloud Computing ETF (SKYY 2.34%). Some of the ETF's holdings, Adobe and Salesforce among them, are front and center on the theme of AI agents disrupting the software space. This ETF presents investors with a potential dilemma. On one hand, it's undoubtedly home to some quality stocks, and there's even a belief in some corners of the AI world that software equities have fallen too far, too fast. Expand NASDAQ : SKYY First Trust Exchange-Traded Fund II - First Trust Cloud Computing ETF Today's Change ( -2.34 %) $ -2.71 Current Price $ 113.07 Key Data Points Day's Range $ 111.76 - $ 117.24 52wk Range $ 85.38 - $ 143.74 Volume 217K On the other hand, at a time when some market o...

格隆汇2月12日｜美国总统特朗普：今年煤电发电量将增长约25%至30%。

Trump says no 'definitive' agreement with Netanyahu, US talks with Iran to continue Reuters

土瓜灣海味舖遭爆竊 失70萬元花膠、魚翅 警拘3人 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】土瓜灣一間海味舖遭爆竊，損失約70萬元貨物，警方拘捕三人。 警方起回大部分贓物，包括花膠、魚翅及海參。案發在星期一早上，馬頭圍道187號一間海味店遭爆竊，警員在現場檢獲螺絲批，相信是犯案工具。翻查閉路電視鎖定疑匪，先後在深水埗及尖沙咀拘捕三名50至66歲男子，相信最年長一人是主腦。他亦懷疑涉及本月荃灣另一宗企圖爆竊案件。

(RTTNews) - Albemarle Corporation (ALB) on Wednesday reported a fourth-quarter net loss of $414.2 million or $3.87 per share, compared to net income of $75.3 million or $0.29 per share last year. Adjusted loss per share for the quarter was $0.53, compared to $1.09 per share last year. Net sales for the quarter were $1.428 billion, compared to $1.232 billion last year. Separately, the company said it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. The announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4. The Kemerton plant processes spodumene from the Greenbushes mine, one of the world's best spodumene resources. Albemarle holds ownership interest and half of the offtake rights from Greenbushes through an Australian joint venture. Kemerton, with its proven technology and commercial scale lithium hydroxide production, was built to enable the development of a Western lithium supply chain. The decision is expected to be accretive to adjusted EBITDA beginning in the second quarter of 2026 with no impact to projected 2026 volumes. Albemarle will meet customer demand for lithium hydroxide through other production channels. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

GREELEY, Colo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results. 2025 Highlights Net Sales of $18.5 billion. Consolidated GAAP Operating Income margin of 8.7%. GAAP Net Income of $1.1 billion and GAAP EPS of $4.54. Adjusted Net Income of $1.2 billion, and Adjusted EPS of $5.17. Adjusted EBITDA of $2.3 billion, or a 12.3% margin, with Adjusted EBITDA margins of 14.8% in the U.S., 8.4% in Europe, and 8.8% in Mexico. Pilgrim’s U.S. Fresh portfolio benefited from robust demand across retail and foodservice. Volume from Key Customers in both Case Ready and Small Bird grew higher than the industry averages. Big Bird drove improvements through enhanced yields, mix, and cost efficiencies. Growth in U.S. Prepared Foods continues to accelerate across retail and foodservice as net sales rose over 20% compared to prior year. In frozen fully cooked, Just Bare ® continues to lead velocity among branded offerings and has grown retail sales by over 50% compared to last year. continues to lead velocity among branded offerings and has grown retail sales by over 50% compared to last year. The company’s diversification efforts through branded offerings achieved a new milestone as Just Bare ® achieved one billion dollars in retail sales across fresh and frozen fully cooked. Total market share has grown from 1% to 13% over the past three years. achieved one billion dollars in retail sales across fresh and frozen fully cooked. Total market share has grown from 1% to 13% over the past three years. Europe continues its improvement journey, through efficiencies in back-office integration, manufacturing footprint optimization, and product innovation. Volume growth of key brands outpaced the overall grocery channel, led by Fridge Raiders ® and Rollover ® . and Rollover . Mexico continued to drive growth. Diversification efforts gained traction as branded sales ...

University of Montana linebacker Solomon Tuliaupupu will be 26 next season, reigniting the conversation around college sports becoming more professional.

(RTTNews) - Cognex Corp (CGNX) released earnings for its fourth quarter that Increases, from last year The company's bottom line totaled $32.66 million, or $0.19 per share. This compares with $28.34 million, or $0.16 per share, last year. Excluding items, Cognex Corp reported adjusted earnings of $46.35 million or $0.27 per share for the period. The company's revenue for the period rose 9.9% to $252.33 million from $229.68 million last year. Cognex Corp earnings at a glance (GAAP) : -Earnings: $32.66 Mln. vs. $28.34 Mln. last year. -EPS: $0.19 vs. $0.16 last year. -Revenue: $252.33 Mln vs. $229.68 Mln last year. -Guidance: Next quarter EPS guidance: $ 0.22 To $ 0.26 Next quarter revenue guidance: $ 235 M To $ 255 M The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Erik Isakson Equinix ( EQIX ) stock jumped 7.8% in Wednesday after-hours trading after the company introduced robust 2026 and Q1 guidance, citing demand for its digital infrastructure, even as Q4 earnings and revenue fell short of the Wall Street consensus estimates. The REIT expects 2026 revenue of $10.123B-$10.223B (midpoint $10.173B vs. consensus $10.1B); AFFO per share of $41.93-$42.74 (midpoint $42.34 vs. consensus $40.92); and adjusted EBITDA of $5.141B-$5.221B with adjusted EBITDA margin of ~51%. For Q1 2026, Equinix ( EQIX ) anticipates revenue of $2.496B-$2.536B (midpoint $2.516B vs. consensus $2.47B) and adjusted EBITDA of $1.283B-$1.323B (midpoint $1.303B). " Demand for our solutions has never been higher, as demonstrated by accelerated growth in both bookings and recurring revenue, and we are confident in our plan to deliver robust revenue and AFFO per share growth in 2026," said President and CEO Adaire Fox-Martin. Q4 AFFO per share of $8.91, missing the Visible Alpha consensus of $9.12, fell from $9.83 in Q3 and increased from $7.92 in Q4 2024. Adjusted EBITDA of $1.19B, missing the Visible Alpha estimate of $1.22B, increased from $1.15B in the prior quarter and $1.02B in the year-ago period. Revenue of $2.42B, lagging the $2.46B consensus, climbed from $2.32B in the prior quarter and $2.26B in the year-ago period. Monthly recurring revenue rose 10% on both an as-reported and a normalized and constant currency basis, vs. 8% in the previous quarter. Q4 annualized gross bookings of $474M vs. $394M in Q3. Total operating expenses of $800M increased from $700M in Q3 and decreased from $962M in Q4 2024. Conference call at 5:30 PM ET. More on Equinix Equinix Is The DC King You Can Buy At A Reasonable Price Equinix: Upcoming Dividend Hike Mitigates Lumpy Execution Against 2029 Target Ditch Digital Realty For Equinix Equinix FFO of $8.91 beats by $1.68, revenue of $2.42B misses by $40M Microsoft unveils plan to manage AI data centers as Trump mulls electricity...

The United States and China are poised to extend the trade truce they negotiated in South Korea by up to a year when President Donald Trump and President Xi Jinping are expected to meet in Beijing in early April, according to several people familiar with the discussions. The uneasy truce , struck last October after a bilateral meeting between the two leaders in Busan, rolled back tariffs and export controls after months of spiralling tensions marked by triple-digit “retaliatory” levies and Beijing’s sweeping boycott of US agricultural goods for much of 2025. Since the reprieve, China has resumed purchases of American soybeans, a politically sensitive crop in the US. Extending the informal months-long understanding, a step seen by officials as realistic and achievable, would anchor the summit around short-term economic wins, including fresh Chinese purchase commitments, the sources said. Advertisement Trump is pressing for tangible deliverables ahead of November’s midterm elections amid mounting concerns about maintaining his congressional majority. After his nearly two-hour-long call with Xi last week, Trump shared that Beijing was considering buying more soybeans from the US. Trump is expected to travel to China in early April, according to four people familiar with the plans. An initial arrival date under consideration was March 31, leading to a bilateral meeting with Xi in the first week of April as part of a visit lasting about three days, two of the people said. 08:58 What are rare earths, and why is China’s dominance facing global pushback What are rare earths, and why is China’s dominance facing global pushback